BRUGADA SYNDROME (BRS)
Clinical trials for BRUGADA SYNDROME (BRS) explained in plain language.
Never miss a new study
Get alerted when new BRUGADA SYNDROME (BRS) trials appear
Sign up with your email to follow new studies for BRUGADA SYNDROME (BRS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes drug fix a rare heart condition?
Disease control Not yet recruitingThis small study will test whether empagliflozin, a drug typically used for diabetes, can improve abnormal heart patterns in people with Brugada syndrome. Ten participants will take the drug daily for three months, and researchers will monitor their heart rhythms and any side eff…
Matched conditions: BRUGADA SYNDROME (BRS)
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:51 UTC
-
Heart risk under the knife: new study tracks anesthesia dangers in rare cardiac condition
Knowledge-focused Not yet recruitingThis observational study will follow 200 adults with Brugada Syndrome who need anesthesia for surgery or other procedures. Researchers want to see how often dangerous heart rhythms occur during and up to 30 days after anesthesia. They will also check if certain anesthetic drugs o…
Matched conditions: BRUGADA SYNDROME (BRS)
Sponsor: Hospital Clinic of Barcelona • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could cancer antibodies trigger heart problems? new study investigates
Knowledge-focused Not yet recruitingThis study will check if people with metastatic breast or colon cancer have antibodies that might also attack the heart. Researchers will collect blood samples and ECGs from 196 participants over 12 months. The goal is to see if these antibodies raise the risk of dangerous heart …
Matched conditions: BRUGADA SYNDROME (BRS)
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC